Spikevax (previously COVID-19 Vaccine Moderna) (monovalent, Original)

(Note 2)Initial Approval

Coronavirus Modified Uridine RNA Vaccine (SARS-CoV-2) (active ingredient: elasomeran)

Approval Information

Brand NameSpikevax (previously COVID-19 Vaccine Moderna) (monovalent, Original)

Generic NameCoronavirus Modified Uridine RNA Vaccine (SARS-CoV-2) (active ingredient: elasomeran)

ApprovedMay 2021

Type(Note 2)Initial Approval

Review Reports

English Review Report

PDF · 723.93 KB

Japanese Review Report

PDF · 1.42 MB

Want structured data, translation summaries & alerts?

PharmaLens is building the most comprehensive English-language PMDA intelligence platform. Join the waitlist for early access.

Join the Waitlist

Source: PMDA Website. Review reports are provided under Japan's Public Data License v1.0. Translations and structured data by PharmaLens are unofficial and for reference only.

← Back to Drug Database